Page last updated: 2024-11-01

nifedipine and Autonomic Hyperreflexia

nifedipine has been researched along with Autonomic Hyperreflexia in 4 studies

Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.

Research Excerpts

ExcerptRelevanceReference
"Current treatment for autonomic dysreflexia (AD) involves rupturing a liquid-filled soft capsule of nifedipine to aid rapid drug release and absorption, however, this application is not covered under the manufacturer's license."8.02Design and characterisation of an amorphous formulation of nifedipine for the treatment of autonomic dysreflexia. ( Browne, E; Cheyne, S; Healy, AM; Quinn, S, 2021)
"Current treatment for autonomic dysreflexia (AD) involves rupturing a liquid-filled soft capsule of nifedipine to aid rapid drug release and absorption, however, this application is not covered under the manufacturer's license."4.02Design and characterisation of an amorphous formulation of nifedipine for the treatment of autonomic dysreflexia. ( Browne, E; Cheyne, S; Healy, AM; Quinn, S, 2021)
"Autonomic dysreflexia is a hypertensive clinical emergency for persons with spinal cord injury at T-6 level or above."1.35Recurrent autonomic dysreflexia due to chronic aortic dissection in an adult male with cervical spinal cord injury. ( Hughes, PL; Oo, T; Soni, BM; Vaidyanathan, S, 2008)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Browne, E1
Quinn, S1
Cheyne, S1
Healy, AM1
Vaidyanathan, S1
Hughes, PL1
Oo, T1
Soni, BM1
Frost, F1
Meagher, A1

Other Studies

4 other studies available for nifedipine and Autonomic Hyperreflexia

ArticleYear
Design and characterisation of an amorphous formulation of nifedipine for the treatment of autonomic dysreflexia.
    The Journal of pharmacy and pharmacology, 2021, Jun-08, Volume: 73, Issue:7

    Topics: Autonomic Dysreflexia; Calcium Channel Blockers; Chemistry Techniques, Synthetic; Drug Compounding;

2021
Recurrent autonomic dysreflexia due to chronic aortic dissection in an adult male with cervical spinal cord injury.
    TheScientificWorldJournal, 2008, Jun-13, Volume: 8

    Topics: Adrenergic alpha-Antagonists; Aortic Rupture; Autonomic Dysreflexia; Calcium Channel Blockers; Cervi

2008
Antihypertensive therapy, nifedipine, and autonomic dysreflexia.
    Archives of physical medicine and rehabilitation, 2002, Volume: 83, Issue:9

    Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Autonomic Dysreflexia; Calcium Ch

2002
Taking a bite out of nifedipine.
    Nursing, 2005, Volume: 35, Issue:10

    Topics: Acute Disease; Autonomic Dysreflexia; Contraindications; Drug Labeling; Humans; Hypertension; Nifedi

2005